
Thyroid Cancer Diagnostics
Thyroid Cancer Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Assay Kits, Instruments, Reagents, Consumables and Other Products), Cancer Type, Test Type, Cancer Stage, Diagnostic Technique, End User and By Geography

According to Stratistics MRC, the Global Thyroid Cancer Diagnostics Market is accounted for $2.82 billion in 2024 and is expected to reach $9.37 billion by 2030 growing at a CAGR of 5.6% during the forecast period. Thyroid cancer diagnostics involve a series of medical evaluations and tests to detect and characterize thyroid cancer. These diagnostic tools help determine the presence, type, and stage of thyroid cancer, guiding appropriate treatment strategies. Early detection enables timely intervention, improving treatment outcomes and survival rates. Accurate diagnosis helps clinicians tailor appropriate treatment plans, minimizing unnecessary procedures and reducing healthcare costs.
According to the American Cancer Society, about 44,280 new thyroid cancer patients may be detected in 2021.
Market Dynamics:
Driver:
Growing focus on tailored treatment plans
Personalized medicine strategies emphasize the importance of precise diagnosis to identify specific genetic mutations or biomarkers associated with the cancer. This necessitates the use of sophisticated diagnostic techniques such as molecular testing and genomic analysis. Consequently, healthcare providers increasingly rely on comprehensive diagnostic approaches to accurately characterize thyroid cancer subtypes, enabling them to tailor treatment regimens according to individual patient needs. This trend fuels the expansion of the thyroid cancer diagnostics market by driving adoption of advanced diagnostic technologies.
Restraint:
False positives and over diagnosis
False positives can lead to unnecessary biopsies, surgeries, and treatments, causing physical and psychological distress to patients. Over diagnosis can result in the unnecessary labeling and treatment of indolent or non-progressive cancers, further burdening healthcare resources. This undermines confidence in diagnostic tests and treatments, discouraging both patients and healthcare providers from utilizing them, thereby impeding market expansion and innovation in the field.
Opportunity:
Increased investments in healthcare infrastructure
Increased investments in healthcare infrastructure enhance access to advanced diagnostic technologies and services. Investments in modern medical facilities, equipment, and training enable healthcare providers to offer more accurate and timely diagnosis of thyroid cancer. Improved infrastructure also facilitates early detection and treatment, leading to better patient outcomes and reduced healthcare costs in the long term. Moreover, expanded healthcare infrastructure fosters research and development, driving innovation and the introduction of new diagnostic methods, further stimulating market growth.
Threat:
Expensive tests and technologies
Thyroid cancer diagnostics often involve expensive tests and technologies due to their complexity and specialized nature. Advanced imaging techniques, molecular testing, and biopsy procedures contribute to high costs. These expenses can deter patients from seeking timely diagnosis and treatment, particularly in regions with limited healthcare resources or inadequate insurance coverage. Moreover, high costs may strain healthcare budgets, limiting access to diagnostic services and impeding market growth.
Covid-19 Impact
The covid-19 pandemic has influenced the thyroid cancer diagnostics market by causing disruptions in healthcare services, including delays in routine screenings and elective procedures. Reduced patient visits to healthcare facilities and reallocation of resources towards managing the pandemic have led to a decline in diagnostic testing volumes. However, increased emphasis on telemedicine and the gradual return to normal healthcare operations are expected to support market recovery post-pandemic.
The advanced-stage diagnosis segment is expected to be the largest during the forecast period
The advanced-stage diagnosis segment is estimated to have a lucrative growth. Advanced-stage thyroid cancer diagnosis focuses on precise and comprehensive evaluation to guide treatment plans. It enables healthcare providers to tailor treatment plans according to the specific characteristics of the cancer, leading to more personalized and targeted therapies. Overall, accurate thyroid cancer diagnostics in advanced stages contribute to better prognosis, quality of life, and overall healthcare resource utilization.
The imaging segment is expected to have the highest CAGR during the forecast period
The imaging segment is anticipated to witness the highest CAGR growth during the forecast period. Imaging cancer diagnostics employ various techniques such as MRI, CT scans, PET scans, ultrasound, and molecular imaging to visualize tumours and assess their characteristics, size, location, and potential metastasis. These non-invasive methods aid in early detection, staging, treatment planning, and monitoring of cancer progression. Advancements like functional and molecular imaging provide insights into tumor biology, guiding personalized treatment approaches for improved patient outcomes.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period due to rising incidences of thyroid cancer, improving healthcare infrastructure, and increasing awareness about early detection. Countries like China, India, and Japan are witnessing a surge in demand for diagnostic tests driven by their large population bases and evolving healthcare systems. Moreover, advancements in diagnostic technologies and government initiatives to improve cancer care further fuel market expansion.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, driven by increasing thyroid cancer incidence, advancements in diagnostic technologies, and rising awareness about early detection. The market benefits from strong healthcare infrastructure and significant investments in research and development. Additionally, the growing adoption of precision medicine and personalized healthcare approaches further propels market expansion in this region. The United States and Canada are the primary contributors to this market growth.
Key players in the market
Some of the key players profiled in the Thyroid Cancer Diagnostics Market include Abbott Laboratories, Roche Limited, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, General Electric, Koninklijke Philips N.V., Toshiba Corporation, Agilent Technologies, Illumina Inc., BioMerieux SA, Biocare Medical LLC, Danaher Corporation, F. Hoffmann-La Roche AG, PerkinElmer Inc., Quest Diagnostics Incorporated and Bayer AG.
Key Developments:
In April 2024, Bio-Rad Laboratories, Inc. launched the ddPLEX ESR1 Mutation Detection Kit, its first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research. The assay is designed for Bio-Rad's QX600™ Droplet Digital™ PCR and can detect, discriminate, and quantify key mutations in the ESR1 gene for breast cancer.
In March 2024, Bayer AG and Thermo Fisher Scientific Inc. announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help identify patients who may benefit from Bayer’s growing portfolio of precision cancer therapies by offering decentralized genomic testing and rapid turnaround time.
Products Covered:
• Assay Kits
• Instruments
• Reagents
• Consumables
• Other Products
Cancer Types Covered:
• Papillary Thyroid Cancer
• Follicular Thyroid Cancer
• Medullary Thyroid Cancer
• Anaplastic Thyroid Cancer
• Other Cancer Types
Test Types Covered:
• Diagnostic Tests
• Monitoring Tests
Cancer Stages Covered:
• Early-Stage Diagnosis
• Advanced-Stage Diagnosis
Diagnostic Techniques Covered:
• Imaging
• Blood Tests
• Molecular Diagnostics
• Biopsy
• Other Diagnostic Techniques
End Users Covered:
• Diagnostic Laboratories
• Academic & Research Institutes
• Specialty Clinics
• Hospitals
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Thyroid Cancer Diagnostics Market, By Product
5.1 Introduction
5.2 Assay Kits
5.3 Instruments
5.4 Reagents
5.5 Consumables
5.6 Other Products
6 Global Thyroid Cancer Diagnostics Market, By Cancer Type
6.1 Introduction
6.2 Papillary Thyroid Cancer
6.3 Follicular Thyroid Cancer
6.4 Medullary Thyroid Cancer
6.5 Anaplastic Thyroid Cancer
6.6 Other Cancer Types
7 Global Thyroid Cancer Diagnostics Market, By Test Type
7.1 Introduction
7.2 Diagnostic Tests
7.3 Monitoring Tests
8 Global Thyroid Cancer Diagnostics Market, By Cancer Stage
8.1 Introduction
8.2 Early-Stage Diagnosis
8.3 Advanced-Stage Diagnosis
9 Global Thyroid Cancer Diagnostics Market, By Diagnostic Technique
9.1 Introduction
9.2 Imaging
9.3 Blood Tests
9.4 Molecular Diagnostics
9.5 Biopsy
9.6 Other Diagnostic Techniques
10 Global Thyroid Cancer Diagnostics Market, By End User
10.1 Introduction
10.2 Diagnostic Laboratories
10.3 Academic & Research Institutes
10.4 Specialty Clinics
10.5 Hospitals
11 Global Thyroid Cancer Diagnostics Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott Laboratories
13.2 Roche Limited
13.3 Thermo Fisher Scientific
13.4 Siemens Healthcare
13.5 Bio-Rad Laboratories
13.6 General Electric
13.7 Koninklijke Philips N.V.
13.8 Toshiba Corporation
13.9 Agilent Technologies
13.10 Illumina Inc.
13.11 BioMerieux SA
13.12 Biocare Medical LLC
13.13 Danaher Corporation
13.14 F. Hoffmann-La Roche AG
13.15 PerkinElmer Inc.
13.16 Quest Diagnostics Incorporated
13.17 Bayer AG
List of Tables
1 Global Thyroid Cancer Diagnostics Market Outlook, By Region (2022-2030) ($MN)
2 Global Thyroid Cancer Diagnostics Market Outlook, By Product (2022-2030) ($MN)
3 Global Thyroid Cancer Diagnostics Market Outlook, By Assay Kits (2022-2030) ($MN)
4 Global Thyroid Cancer Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
5 Global Thyroid Cancer Diagnostics Market Outlook, By Reagents (2022-2030) ($MN)
6 Global Thyroid Cancer Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
7 Global Thyroid Cancer Diagnostics Market Outlook, By Other Products (2022-2030) ($MN)
8 Global Thyroid Cancer Diagnostics Market Outlook, By Cancer Type (2022-2030) ($MN)
9 Global Thyroid Cancer Diagnostics Market Outlook, By Papillary Thyroid Cancer (2022-2030) ($MN)
10 Global Thyroid Cancer Diagnostics Market Outlook, By Follicular Thyroid Cancer (2022-2030) ($MN)
11 Global Thyroid Cancer Diagnostics Market Outlook, By Medullary Thyroid Cancer (2022-2030) ($MN)
12 Global Thyroid Cancer Diagnostics Market Outlook, By Anaplastic Thyroid Cancer (2022-2030) ($MN)
13 Global Thyroid Cancer Diagnostics Market Outlook, By Other Cancer Types (2022-2030) ($MN)
14 Global Thyroid Cancer Diagnostics Market Outlook, By Test Type (2022-2030) ($MN)
15 Global Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Tests (2022-2030) ($MN)
16 Global Thyroid Cancer Diagnostics Market Outlook, By Monitoring Tests (2022-2030) ($MN)
17 Global Thyroid Cancer Diagnostics Market Outlook, By Cancer Stage (2022-2030) ($MN)
18 Global Thyroid Cancer Diagnostics Market Outlook, By Early-Stage Diagnosis (2022-2030) ($MN)
19 Global Thyroid Cancer Diagnostics Market Outlook, By Advanced-Stage Diagnosis (2022-2030) ($MN)
20 Global Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Technique (2022-2030) ($MN)
21 Global Thyroid Cancer Diagnostics Market Outlook, By Imaging (2022-2030) ($MN)
22 Global Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2022-2030) ($MN)
23 Global Thyroid Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
24 Global Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2022-2030) ($MN)
25 Global Thyroid Cancer Diagnostics Market Outlook, By Other Diagnostic Techniques (2022-2030) ($MN)
26 Global Thyroid Cancer Diagnostics Market Outlook, By End User (2022-2030) ($MN)
27 Global Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
28 Global Thyroid Cancer Diagnostics Market Outlook, By Academic & Research Institutes (2022-2030) ($MN)
29 Global Thyroid Cancer Diagnostics Market Outlook, By Specialty Clinics (2022-2030) ($MN)
30 Global Thyroid Cancer Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.